Ad is loading...
BEAM
Price
$28.31
Change
+$0.94 (+3.43%)
Updated
Dec 2, 04:00 PM (EDT)
92 days until earnings call
CARM
Price
$0.85
Change
-$0.00 (-0.00%)
Updated
Dec 2, 04:02 PM (EDT)
Ad is loading...

BEAM vs CARM

Header iconBEAM vs CARM Comparison
Open Charts BEAM vs CARMBanner chart's image
Beam Therapeutics
Price$28.31
Change+$0.94 (+3.43%)
Volume$158.83K
CapitalizationN/A
Carisma Therapeutics
Price$0.85
Change-$0.00 (-0.00%)
Volume$1.03K
CapitalizationN/A
BEAM vs CARM Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. CARM commentary
Dec 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and CARM is a Hold.

COMPARISON
Comparison
Dec 02, 2024
Stock price -- (BEAM: $27.37 vs. CARM: $0.85)
Brand notoriety: BEAM and CARM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 54% vs. CARM: 33%
Market capitalization -- BEAM: $2.27B vs. CARM: $35.66M
BEAM [@Biotechnology] is valued at $2.27B. CARM’s [@Biotechnology] market capitalization is $35.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.43B to $0. The average market capitalization across the [@Biotechnology] industry is $2.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCARM’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CARM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while CARM’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • CARM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CARM.

Price Growth

BEAM (@Biotechnology) experienced а +9.26% price change this week, while CARM (@Biotechnology) price change was +3.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.48%. For the same industry, the average monthly price growth was +2.46%, and the average quarterly price growth was +11.09%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

CARM is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Biotechnology (+4.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.27B) has a higher market cap than CARM($35.7M). BEAM YTD gains are higher at: 0.551 vs. CARM (-70.846). CARM has higher annual earnings (EBITDA): -63.37M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. CARM (26.9M). CARM has less debt than BEAM: CARM (3.32M) vs BEAM (162M). BEAM has higher revenues than CARM: BEAM (350M) vs CARM (20.3M).
BEAMCARMBEAM / CARM
Capitalization2.27B35.7M6,347%
EBITDA-160.83M-63.37M254%
Gain YTD0.551-70.846-1%
P/E RatioN/AN/A-
Revenue350M20.3M1,724%
Total Cash926M26.9M3,442%
Total Debt162M3.32M4,884%
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCARM
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NIQEX13.650.16
+1.19%
Neuberger Berman International Eq E
CSPYX26.640.06
+0.23%
Columbia Small Cap Index Inst3
BMPEX28.670.06
+0.21%
Beck Mack + Oliver Partners
OIERX27.540.04
+0.15%
JPMorgan Equity Income R5
RSENX19.56-0.03
-0.15%
Victory Sophus Emerging Markets Y

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with PRME. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
+1.57%
PRME - CARM
39%
Loosely correlated
-0.30%
BEAM - CARM
37%
Loosely correlated
+0.63%
ARDX - CARM
35%
Loosely correlated
-0.35%
IOVA - CARM
35%
Loosely correlated
-0.85%
ABCL - CARM
35%
Loosely correlated
+0.33%
More